Funding for this research was provided by:
Bröstcancerföreningarnas Riksorganisation BRO (2163)
Regionala forskningsrådet Uppsala-Örebro (RFR-525561)
Centrum för klinisk forskning Värmland (2169)
Received: 17 April 2017
Accepted: 9 February 2018
First Online: 20 February 2018
Ethics approval and consent to participate
: The Regional Ethical Review Board at Uppsala University approved the study, Dnr: 2015/30. If the patient responded to, and returned, the questionnaires, it was regarded as informed consent for inclusion in the study, a consent procedure approved by the Regional Ethical Review Board at Uppsala University. Permissions were required and received for accessing hospital medical records and databases.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.